A Randomized, Double-Blind, Four-Period, Crossover Study to Evaluate the Cardiovascular Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2019
Price : $35 *
At a glance
- Drugs Lasmiditan (Primary) ; Sumatriptan (Primary)
- Indications Migraine
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 19 Jan 2018 Status changed from recruiting to completed.
- 20 Oct 2017 Status changed from not yet recruiting to recruiting.
- 19 Oct 2017 New trial record